(19)
(11) EP 1 187 580 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.06.2006 Bulletin 2006/26

(45) Mention of the grant of the patent:
12.04.2006 Bulletin 2006/15

(21) Application number: 00941265.1

(22) Date of filing: 07.06.2000
(51) International Patent Classification (IPC): 
A61F 2/14(2006.01)
(86) International application number:
PCT/US2000/015691
(87) International publication number:
WO 2000/074600 (14.12.2000 Gazette 2000/50)

(54)

IMPROVED SCLERAL PROSTHESIS FOR TREATMENT OF PRESBYOPIA AND OTHER EYE DISORDERS

SKLERAPROTHESE ZUR BEHANDLUNG DER WEITSICHTIGKEIT UND ANDERER AUGENKRANKHEITEN

PROTHESES SCLERALES AMELIOREES POUR LE TRAITEMENT DE LA PRESBYTIE ET AUTRES TROUBLES DE LA VUE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 07.06.1999 US 138105 P

(43) Date of publication of application:
20.03.2002 Bulletin 2002/12

(60) Divisional application:
06007630.4
06075921.4

(73) Proprietor: Refocus Ocular, Inc.
Dallas, TX 75231 (US)

(72) Inventor:
  • SCHACHAR,Ronald A.
    Dallas, TX 75229 (US)

(74) Representative: Driver, Virginia Rozanne et al
Page White & Farrer 54 Doughty Street
London WC1N 2LS
London WC1N 2LS (GB)


(56) References cited: : 
WO-A-96/40005
WO-A-99/17691
 WO-A-98/42409
FR-A- 2 784 287
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).